Historical record - last NADAC effective date: 6/23/2021
Product Information
COUGH DM ER 30 MG/5 ML SUSP is a generic product labeled by Topco Associates LLC, priced at $0.0619 per ML under NDC 36800055221. Its NADAC has been published 83 times since Dec 14, 2016.
FDA first approved this application on May 25, 2012.
Strength
30 mg/5mL
Manufacturer
Topco Associates LLCNDC
36800055221
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091135FDA Approved
5/25/2012
On Market Since
8/30/2012
Pharmacological Classes
Price Statistics
The NADAC for COUGH DM ER 30 MG/5 ML SUSP has been published 83 times since Dec 14, 2016, and over the history we have for it it has risen 11.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0619 per ML |
|---|---|
| All-time high | $0.0619 (Jun 30, 2021) |
| All-time low | $0.0545 (Aug 23, 2017) |
| Median price | $0.0557 |
| Average price | $0.0563 |
| Largest weekly change | +5.0% (Feb 17, 2021) |
| Weeks tracked | 83 |
| Tracking since | Dec 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+11.2%
Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Topco Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan polistirex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COUGH DM ER 30 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for COUGH DM ER 30 MG/5 ML SUSP, manufactured by Topco Associates LLC, is $0.0619 per ML (NDC 36800055221), effective Jun 30, 2021.
How has the price of COUGH DM ER 30 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for COUGH DM ER 30 MG/5 ML SUSP has risen 11.2%. It has been tracked across 83 weekly CMS publications since Dec 14, 2016.
What are the highest and lowest recorded NADAC prices for COUGH DM ER 30 MG/5 ML SUSP?
Since Dec 14, 2016, the NADAC for COUGH DM ER 30 MG/5 ML SUSP has ranged from a low of $0.0545 (Aug 23, 2017) to a high of $0.0619 (Jun 30, 2021), with a median of $0.0557 per ML.
Are there cheaper alternatives to COUGH DM ER 30 MG/5 ML SUSP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, COUGH DM ER 30 MG/5 ML SUSP, is $0.0525 per ML — about 15% below COUGH DM ER 30 MG/5 ML SUSP.
Who manufactures COUGH DM ER 30 MG/5 ML SUSP?
COUGH DM ER 30 MG/5 ML SUSP (NDC 36800055221) is labeled by Topco Associates LLC, and CMS classifies it as a generic product.